Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1965 1
1972 1
1973 1
1974 2
1975 2
1976 4
1977 1
1978 3
1979 4
1980 3
1981 2
1982 7
1983 4
1984 13
1985 19
1986 16
1987 42
1988 55
1989 72
1990 86
1991 73
1992 94
1993 100
1994 101
1995 107
1996 109
1997 144
1998 121
1999 128
2000 122
2001 155
2002 159
2003 223
2004 230
2005 198
2006 254
2007 288
2008 294
2009 331
2010 301
2011 312
2012 330
2013 357
2014 370
2015 375
2016 395
2017 386
2018 392
2019 364
2020 398
2021 341
2022 337
2023 403
2024 104

Text availability

Article attribute

Article type

Publication date

Search Results

8,023 results

Results by year

Filters applied: . Clear all
Page 1
Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.
Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Bahadoram S, et al. G Ital Nefrol. 2022 Jun 20;39(3):2022-vol3. G Ital Nefrol. 2022. PMID: 35819037 Free article. Review.
Renal cell carcinoma (RCC) is the most common type of urogenital cancer. ...The most common type of RCC, based on histological and molecular subtypes, is clear cell carcinoma which occurs frequently due to mutations in the VHL gene. ...
Renal cell carcinoma (RCC) is the most common type of urogenital cancer. ...The most common type of RCC, based on histo …
Renal cell carcinoma.
Rini BI, Campbell SC, Escudier B. Rini BI, et al. Lancet. 2009 Mar 28;373(9669):1119-32. doi: 10.1016/S0140-6736(09)60229-4. Epub 2009 Mar 5. Lancet. 2009. PMID: 19269025 Free article. Review.
Considerable progress has been made in the treatment of patients with renal cell carcinoma, with innovative surgical and systemic strategies revolutionising the management of this disease. ...The effectiveness of immunotherapy, although previously widely used …
Considerable progress has been made in the treatment of patients with renal cell carcinoma, with innovative surgical an …
Renal Cell Carcinoma: Diagnosis and Management.
Gray RE, Harris GT. Gray RE, et al. Am Fam Physician. 2019 Feb 1;99(3):179-184. Am Fam Physician. 2019. PMID: 30702258 Free article. Review.
Kidney cancer is one of the 10 most common cancers in the United States with 90% being attributed to renal cell carcinoma. Men, especially black men, are more likely to be affected than women. Renal masses, either cystic or solid, are best detected wit …
Kidney cancer is one of the 10 most common cancers in the United States with 90% being attributed to renal cell carcinoma …
Papillary renal cell carcinoma: Review.
Mendhiratta N, Muraki P, Sisk AE Jr, Shuch B. Mendhiratta N, et al. Urol Oncol. 2021 Jun;39(6):327-337. doi: 10.1016/j.urolonc.2021.04.013. Epub 2021 May 24. Urol Oncol. 2021. PMID: 34034966 Review.
Kidney cancer is the 13th most common malignancy globally, and the incidence is rising. Papillary renal cell carcinoma is the second most common subtype, comprising 10-15% of renal cell carcinomas. ...In this review, we summarize the contemporar …
Kidney cancer is the 13th most common malignancy globally, and the incidence is rising. Papillary renal cell carcinoma …
Prognostic factors and prognostic models for renal cell carcinoma: a literature review.
Klatte T, Rossi SH, Stewart GD. Klatte T, et al. World J Urol. 2018 Dec;36(12):1943-1952. doi: 10.1007/s00345-018-2309-4. Epub 2018 Apr 30. World J Urol. 2018. PMID: 29713755 Review.
PURPOSE: Following curative treatment for localised renal cell carcinoma (RCC), up to 30% of patients develop tumour recurrence. ...
PURPOSE: Following curative treatment for localised renal cell carcinoma (RCC), up to 30% of patients develop tumour re …
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
Lobo J, Ohashi R, Amin MB, Berney DM, Compérat EM, Cree IA, Gill AJ, Hartmann A, Menon S, Netto GJ, Raspollini MR, Rubin MA, Tan PH, Tickoo SK, Tsuzuki T, Turajlic S, Zhou M, Srigley JR, Moch H. Lobo J, et al. Histopathology. 2022 Oct;81(4):426-438. doi: 10.1111/his.14700. Epub 2022 Jun 10. Histopathology. 2022. PMID: 35596618 Review.
The WHO 2022 classification eliminated the type 1/2 papillary renal cell carcinoma (pRCC) subcategorization, given the recognition of frequent mixed tumour phenotypes and the existence of entities with a different molecular background within the type 2 pRCC c …
The WHO 2022 classification eliminated the type 1/2 papillary renal cell carcinoma (pRCC) subcategorization, given the …
Comprehensive review of chromophobe renal cell carcinoma.
Garje R, Elhag D, Yasin HA, Acharya L, Vaena D, Dahmoush L. Garje R, et al. Crit Rev Oncol Hematol. 2021 Apr;160:103287. doi: 10.1016/j.critrevonc.2021.103287. Epub 2021 Mar 19. Crit Rev Oncol Hematol. 2021. PMID: 33753250 Free article. Review.
Chromophobe renal cell carcinoma (chRCC) is the third most common type of RCC with distinct biology compared to other kidney cancer subtypes. ...ChRCC is characterized by chromosomal aneuploidy, TP53, PTEN, and mitochondrial gene mutations. Though the therape …
Chromophobe renal cell carcinoma (chRCC) is the third most common type of RCC with distinct biology compared to other k …
Renal cell carcinoma.
Jonasch E, Gao J, Rathmell WK. Jonasch E, et al. BMJ. 2014 Nov 10;349:g4797. doi: 10.1136/bmj.g4797. BMJ. 2014. PMID: 25385470 Free PMC article. Review.
The treatment of renal cell carcinoma (RCC) has changed greatly over the past 15 years. ...
The treatment of renal cell carcinoma (RCC) has changed greatly over the past 15 years. ...
What's new in the WHO 2022 classification of kidney tumours?
Alaghehbandan R, Siadat F, Trpkov K. Alaghehbandan R, et al. Pathologica. 2022 Feb;115(1):8-22. doi: 10.32074/1591-951X-818. Epub 2023 Jan 16. Pathologica. 2022. PMID: 36645398 Free PMC article. Review.
A major change in this edition is the grouping of renal tumours into broader categories that include "clear cell renal tumours", "papillary renal tumours", "oncocytic and chromophobe renal tumours", "collecting duct tumours" as well as adding tw …
A major change in this edition is the grouping of renal tumours into broader categories that include "clear cell renal …
Renal-cell carcinoma.
Cohen HT, McGovern FJ. Cohen HT, et al. N Engl J Med. 2005 Dec 8;353(23):2477-90. doi: 10.1056/NEJMra043172. N Engl J Med. 2005. PMID: 16339096 Review. No abstract available.
8,023 results